Amphastar has gained the Food and Drug Administration’s tentative nod for vasopressin injection, 20 units/mL, 1mL single dose vial. Vasopressin is indicated to increase blood pressure in adults with ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of Vasopressin Injection, USP, a generic equivalent to Vasostrict ®. Fresenius Kabi Vasopressin ...

The FDA has announced American Regent is conducting a nationwide voluntary recall of 17 lots of vasopressin injection, USP, multiple-dose vials, due to sub-potency. The recall includes five lots of ...

August 4, 2011 — American Regent, Inc, has announced a voluntary recall of certain lots of multiple-dose vials of its vasopressin injection, after questions were raised over a loss of potency of the ...

Aurobindo Pharma announced that its wholly owned subsidiary company Eugia Pharma Specialties has received a final approval from the US Food Drug Administration USFDA to manufacture and market ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the ...

Par announced it has received approval from the Food and Drug Administration (FDA) for its New Drug Application for Vasostrict (vasopressin injection), the first vasopressin injection to be approved.

American Regent is conducting a nationwide voluntary recall of multiple lots of vasopressin injection because some vials may not maintain potency throughout their shelf-life. Potential adverse events ...

For more than a century, epinephrine has been the drug of choice for vasopressor therapy during cardiopulmonary resuscitation (CPR), but its use has also been linked to ventricular arrhythmias, ...

High-Volume Medication is Formulated, Filled and Packaged in the U.S. LAKE ZURICH, Ill.--(BUSINESS WIRE)--#FreseniusKabi--Fresenius Kabi announced today the availability in the United States of ...

Chirag and Chintu Patel, Co-Chief Executive Officers, stated, “We are pleased to add these four new products to our essential medicines portfolio. Most notably, Vasopressin expands our injectables ...